Healthcare -
Biotechnology - NASDAQ - US
$ 4.16
-11.7 %
$ 86.5 M
Market Cap
-0.7
P/E
ADVM - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ADVM - Adverum Biotechnologies, Inc.
69 K
LAST VALUE
-83.03%
2 YEAR CAGR
-74.95%
5 YEAR CAGR
-30.11%
10 YEAR CAGR